Thermo Fisher Scientific Inc (TMO) Holdings Raised by Bank of Hawaii

Bank of Hawaii raised its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 0.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,105 shares of the medical research company’s stock after acquiring an additional 163 shares during the period. Bank of Hawaii’s holdings in Thermo Fisher Scientific were worth $3,159,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Sharkey Howes & Javer increased its position in shares of Thermo Fisher Scientific by 1.0% during the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after acquiring an additional 7 shares during the last quarter. Beacon Trust Co. increased its position in shares of Thermo Fisher Scientific by 0.6% during the first quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock valued at $341,000 after acquiring an additional 12 shares during the last quarter. Reinhart Partners Inc. increased its position in shares of Thermo Fisher Scientific by 0.6% during the second quarter. Reinhart Partners Inc. now owns 3,430 shares of the medical research company’s stock valued at $598,000 after acquiring an additional 20 shares during the last quarter. Investment Centers of America Inc. increased its position in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock valued at $230,000 after acquiring an additional 21 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH increased its position in shares of Thermo Fisher Scientific by 0.4% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock valued at $1,090,000 after acquiring an additional 23 shares during the last quarter. Institutional investors and hedge funds own 83.61% of the company’s stock.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 360 shares of the stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the sale, the director now owns 5,312 shares of the company’s stock, valued at $961,312.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Gregory J. Herrema sold 30,000 shares of the stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $176.02, for a total transaction of $5,280,600.00. Following the completion of the sale, the senior vice president now directly owns 67,016 shares of the company’s stock, valued at approximately $11,796,156.32. The disclosure for this sale can be found here. Insiders sold 52,738 shares of company stock valued at $9,302,112 in the last ninety days. 0.49% of the stock is owned by corporate insiders.

A number of research analysts recently weighed in on the stock. Deutsche Bank AG set a $226.00 price objective on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Thursday, October 26th. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Tuesday, September 12th. Leerink Swann lifted their price objective on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a report on Monday, October 9th. Cowen and Company restated an “outperform” rating and issued a $220.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Finally, Barclays PLC restated an “overweight” rating and issued a $215.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. Two investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Thermo Fisher Scientific presently has a consensus rating of “Buy” and an average price target of $205.50.

Thermo Fisher Scientific Inc (TMO) opened at 192.02 on Tuesday. The firm’s 50-day moving average is $191.74 and its 200 day moving average is $178.77. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $201.20. The firm has a market cap of $74.91 billion, a PE ratio of 33.45 and a beta of 1.05.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter last year, the company earned $2.03 earnings per share. Thermo Fisher Scientific’s revenue for the quarter was up 13.9% on a year-over-year basis. Equities research analysts predict that Thermo Fisher Scientific Inc will post $9.36 EPS for the current year.

WARNING: This article was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another site, it was illegally copied and reposted in violation of US and international copyright legislation. The correct version of this article can be read at https://www.com-unik.info/2017/10/31/thermo-fisher-scientific-inc-tmo-holdings-raised-by-bank-of-hawaii.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit